Telehealth Intervention for Financial Hardship in Caregivers
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether telehealth (online health support) can help caregivers of patients undergoing specific cancer surgery reduce financial stress and improve quality of life. The trial focuses on providing caregivers with resources and support to manage their unique challenges. Participants will either receive a telehealth intervention (virtual behavioral intervention) with access to helpful resources or continue with their usual caregiving routine. Suitable candidates for this trial are primary caregivers for someone about to undergo particular cancer surgery and have access to a computer or smartphone.
As an unphased trial, this study offers a unique opportunity to access innovative support methods that could significantly enhance the caregiving experience.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications.
What prior data suggests that this telehealth intervention is safe for caregivers?
Past studies have found telehealth services for caregivers to be safe and well-liked. Most caregivers reported satisfaction and comfort with these services, finding the tools easy to use. Research has shown that over 95% of studies reported significant improvements in caregiver well-being. This indicates that telehealth is both helpful and safe for caregivers. Therefore, based on past research, participating in this trial for a telehealth service should not raise any safety concerns.12345
Why are researchers excited about this trial?
Researchers are excited about this telehealth intervention because it offers a novel way to support caregivers experiencing financial hardship. Unlike traditional in-person support services, this intervention is delivered remotely, making it more accessible and convenient for caregivers who may have time or transportation constraints. Additionally, the intervention is personalized, with participants receiving tailored referrals to resources that can directly address their unique caregiving challenges, all before the patient's surgery. This proactive approach not only aims to ease financial stress but also enhances the overall caregiving experience.
What evidence suggests that this telehealth intervention is effective for reducing financial stress in caregivers?
Studies have shown that telehealth programs can effectively improve mental health for caregivers. Participants in these programs have reported feeling less depressed and anxious. In this trial, Group 1 will receive a telehealth intervention, which may include referrals to specific resources for their caregiving experience. Research also shows that telehealth helps caregivers by providing regular support and expert advice. This method has been linked to better outcomes for caregivers, such as reduced stress and improved ability to handle caregiving challenges. Overall, telehealth offers a promising way to support caregivers' mental and emotional well-being.12467
Are You a Good Fit for This Trial?
This trial is for primary caregivers of patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS+HIPEC). It aims to help those experiencing high levels of depression and financial stress due to their caregiving responsibilities.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive telehealth navigation intervention which may consist of referral to specific resources for caregiving experience
Follow-up
Participants are monitored for outcomes such as financial distress, depression, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Telehealth Intervention
Telehealth Intervention is already approved in United States for the following indications:
- Attention Deficit Hyperactivity Disorder (ADHD) in preschoolers
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
National Cancer Institute (NCI)
Collaborator